Sign up
Pharma Capital

Genedrive chief operating officer Allan Brown to step down

Genedrive's COO is stepping down after three years in the role
Genedrive is making changes to its management structure

Genedrive PLC (LON:GDR) said chief operating officer Allan Brown is to leave the company.

Brown will step down after 31 January 2018 to ensure a smooth handover, the company said.

"Allan joined the company in 2014 and has played a key role in the development of the genedrive instrument and tests," said non-executive chairman, Ian Gilham.

"On behalf of the board I'd like to thank Allan for his contributions and wish him the very best in his future plans."

The announcement comes a month after the company’s full year results, which revealed a 13.7% rise in turnover thanks to a rise in development income and improved services income.

READ: Genedrive highlights improved turnover as it releases first full year results since reboot

View full GDR profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.